Please Wait.....
Report
Meningococcal Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Report I 2023-11-02 I 149 Pages I IMARC Group
The global meningococcal vaccines market size reached US$ 3.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2028, exhibiting a growth rate (CAGR) of 8.9% during 2022-2028.
Meningococcal vaccine refers to a biological substance administered for the prevention of meningitis, which is a contagious infection of the membranes surrounding the spinal cord and the brain. The three main kinds of meningococcal vaccines include conjugate, polysaccharide and subcapsular meningococcal vaccines. They are administered to infants, children and adults to immunize them against the invasive disease and target meningococcal bacteria A, B, C, W-135 and Y. Once the vaccine is administered, antibodies are formed to fight the bacteria and create an immune response to prevent the infection in the future.
The increasing prevalence of the meningococcal disease among young children and adolescents across the globe represents one of the key factors driving the growth of the market. Furthermore, the rising health consciousness among the masses and the adoption of routine immunization are providing a thrust to the market growth. Meningococcal vaccine aids in preventing the disease and minimizing the long-term effects, such as temporary or permanent deafness, loss of vision and motor skills, seizure and neurological damage. In line with this, governments of both developed and emerging economies are launching extensive public health programs while emphasizing on the immunization of special risk groups, such as tourists and military personnel, to contain the risks of infections. Additionally, various product innovations, such as the development of ready-to-use liquid formulations that do not require reconstitution, are also contributing to the market growth. Other factors, including extensive research and development (R&D) activities, along with improvements in the healthcare infrastructure, are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global meningococcal vaccines market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on vaccine type, composition, vaccine serotype, distribution channel and end user.
Breakup by Vaccine Type:
Conjugate
Polysaccharide
Subcapsular
Breakup by Composition:
Mono Vaccines
Combination Vaccines
Breakup by Vaccine Serotype:
MenACWY
MenB & Manic
MenC
MenA
MenAC
Others
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Institutional Sales
Others
Breakup by End User:
Pediatric
Adult
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being GlaxoSmithKline Plc, Hualan Biological Engineering Inc., Incepta Pharmaceuticals Limited, Novartis AG, Pfizer Inc., Sanofi S.A., Serum Institute of India Ltd. and Walvax Biotechnology Co. Ltd.
Key Questions Answered in This Report:
How has the global meningococcal vaccines market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global meningococcal vaccines market?
What are the key regional markets?
What is the breakup of the market based on the vaccine type?
What is the breakup of the market based on the composition?
What is the breakup of the market based on the vaccine serotype?
What is the breakup of the market based on the distribution channel?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global meningococcal vaccines market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1Objectives of the Study
2.2Stakeholders
2.3Data Sources
2.3.1Primary Sources
2.3.2Secondary Sources
2.4Market Estimation
2.4.1Bottom-Up Approach
2.4.2Top-Down Approach
2.5Forecasting Methodology
3 Executive Summary
4 Introduction
4.1Overview
4.2Key Industry Trends
5 Global Meningococcal Vaccines Market
5.1Market Overview
5.2Market Performance
5.3Impact of COVID-19
5.4Market Forecast
6 Market Breakup by Vaccine Type
6.1Conjugate
6.1.1 Market Trends
6.1.2 Market Forecast
6.2Polysaccharide
6.2.1 Market Trends
6.2.2 Market Forecast
6.3Subcapsular
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Composition
7.1Mono Vaccines
7.1.1 Market Trends
7.1.2 Market Forecast
7.2Combination Vaccines
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Vaccine Serotype
8.1MenACWY
8.1.1 Market Trends
8.1.2 Market Forecast
8.2MenB & Manic
8.2.1 Market Trends
8.2.2 Market Forecast
8.3MenC
8.3.1 Market Trends
8.3.2 Market Forecast
8.4MenA
8.4.1 Market Trends
8.4.2 Market Forecast
8.5MenAC
8.5.1 Market Trends
8.5.2 Market Forecast
8.6Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1Hospital Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3Institutional Sales
9.3.1 Market Trends
9.3.2 Market Forecast
9.4Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by End User
10.1Pediatric
10.1.1 Market Trends
10.1.2 Market Forecast
10.2Adult
10.2.1 Market Trends
10.2.2 Market Forecast
11 Market Breakup by Region
11.1North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2Asia Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1Overview
12.2Strengths
12.3Weaknesses
12.4Opportunities
12.5Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1Overview
14.2Bargaining Power of Buyers
14.3Bargaining Power of Suppliers
14.4Degree of Competition
14.5Threat of New Entrants
14.6Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1Market Structure
16.2Key Players
16.3Profiles of Key Players
16.3.1GlaxoSmithKline Plc
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2Hualan Biological Engineering Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.3Incepta Pharmaceuticals Limited
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.4Novartis AG
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5Pfizer Inc.
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6Sanofi S.A.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7Serum Institute of India Ltd.
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.8Walvax Biotechnology Co. Ltd.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
Figure 1: Global: Meningococcal Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Meningococcal Vaccines Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Meningococcal Vaccines Market: Breakup by Vaccine Type (in %), 2022
Figure 4: Global: Meningococcal Vaccines Market: Breakup by Composition (in %), 2022
Figure 5: Global: Meningococcal Vaccines Market: Breakup by Vaccine Serotype (in %), 2022
Figure 6: Global: Meningococcal Vaccines Market: Breakup by Distribution Channel (in %), 2022
Figure 7: Global: Meningococcal Vaccines Market: Breakup by End User (in %), 2022
Figure 8: Global: Meningococcal Vaccines Market: Breakup by Region (in %), 2022
Figure 9: Global: Meningococcal Vaccines Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 10: Global: Meningococcal Vaccines (Conjugate) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Meningococcal Vaccines (Conjugate) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Meningococcal Vaccines (Polysaccharide) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Meningococcal Vaccines (Polysaccharide) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Meningococcal Vaccines (Subcapsular) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Meningococcal Vaccines (Subcapsular) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Meningococcal Vaccines (Mono Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Meningococcal Vaccines (Mono Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Meningococcal Vaccines (Combination Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Meningococcal Vaccines (Combination Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Meningococcal Vaccines (MenACWY) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Meningococcal Vaccines (MenACWY) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Meningococcal Vaccines (MenB & Manic) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Meningococcal Vaccines (MenB & Manic) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Meningococcal Vaccines (MenC) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Meningococcal Vaccines (MenC) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Meningococcal Vaccines (MenA) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Meningococcal Vaccines (MenA) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Meningococcal Vaccines (MenAC) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Meningococcal Vaccines (MenAC) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Meningococcal Vaccines (Other Vaccine Serotypes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Meningococcal Vaccines (Other Vaccine Serotypes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Meningococcal Vaccines (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Meningococcal Vaccines (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Meningococcal Vaccines (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Meningococcal Vaccines (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Meningococcal Vaccines (Institutional Sales) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Meningococcal Vaccines (Institutional Sales) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Meningococcal Vaccines (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Meningococcal Vaccines (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Global: Meningococcal Vaccines (Pediatric) Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Global: Meningococcal Vaccines (Pediatric) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Global: Meningococcal Vaccines (Adult) Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Global: Meningococcal Vaccines (Adult) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: North America: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: North America: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: United States: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: United States: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Canada: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Canada: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Asia Pacific: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Asia Pacific: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: China: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: China: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Japan: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Japan: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: India: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: India: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: South Korea: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: South Korea: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Australia: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Australia: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Indonesia: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Indonesia: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Others: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Others: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Europe: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Europe: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Germany: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Germany: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: France: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: France: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: United Kingdom: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: United Kingdom: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Italy: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Italy: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Spain: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Spain: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Russia: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Russia: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Others: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Others: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Latin America: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Latin America: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Brazil: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Brazil: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Mexico: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Mexico: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 88: Others: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 89: Others: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 90: Middle East and Africa: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 91: Middle East and Africa: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 92: Global: Meningococcal Vaccines Industry: SWOT Analysis
Figure 93: Global: Meningococcal Vaccines Industry: Value Chain Analysis
Figure 94: Global: Meningococcal Vaccines Industry: Porters Five Forces Analysis
Table 1: Global: Meningococcal Vaccines Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Meningococcal Vaccines Market Forecast: Breakup by Vaccine Type (in Million US$), 2023-2028
Table 3: Global: Meningococcal Vaccines Market Forecast: Breakup by Composition (in Million US$), 2023-2028
Table 4: Global: Meningococcal Vaccines Market Forecast: Breakup by Vaccine Serotype (in Million US$), 2023-2028
Table 5: Global: Meningococcal Vaccines Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 6: Global: Meningococcal Vaccines Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 7: Global: Meningococcal Vaccines Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 8: Global: Meningococcal Vaccines Market: Competitive Structure
Table 9: Global: Meningococcal Vaccines Market: Key Players
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security